Firm at a glance
Polaris Capital Group is a platform private equity firm headquartered in Tokyo, with additional offices in Osaka and Singapore, per its own website [S1].
What they buy
Based on publicly disclosed portfolio holdings, Polaris Capital Group appears to focus on Japanese middle-market companies across four primary sectors: healthcare and welfare, IT services and logistics, technology and manufacturing, and consumer goods and retail [S2]. The firm’s portfolio consists exclusively of platform investments rather than add-on acquisitions, suggesting a strategy centered on building independent portfolio companies [S2]. Recent activity indicates continued interest in healthcare infrastructure, business services, and technology-enabled businesses within Japan and select international markets.
Portfolio
Healthcare and welfare
* Ospherion Biomaterial / FH Ortho SAS (platform, July 2024) [S2]
* Wellbe (platform, April 2024) [S2]
* Social Increw (platform, November 2022) [S2]
* Eclasia (platform, July 2022) [S2]
IT services and logistics
* Softbrain (platform, January 2026) [S2]
* Stockmark (platform, November 2024) [S2]
* KAIGI (platform, March 2023) [S2]
* Geo Technologies, formerly Increment P (platform, June 2021) [S2]
* Ornet (platform, December 2018) [S2]
Technology and manufacturing
* B Food Science (platform, February 2025) [S2]
* i-PRO (platform, November 2019) [S2]
* FCNT / Japan EM Solutions (platform, March 2018) [S2]
Consumer goods and retail
* DD Group (platform, September 2025) [S2]
* LB (platform, November 2017) [S2]
* BAKE (platform, August 2017) [S2]
Recent activity (last 24 months)
* Acquisition of Softbrain, January 2026 [S2]
* Acquisition of DD Group, September 2025 [S2]
* Exit of Space Value Holdings, July 2025 [S2]
* Exit of Linkstec, April 2025 [S2]
* Acquisition of B Food Science, February 2025 [S2]
* Acquisition of Stockmark, November 2024 [S2]
* Acquisition of Ospherion Biomaterial / FH Ortho SAS, July 2024 [S2]
* Acquisition of Wellbe, April 2024 [S2]
* Exit of General Medical Group, February 2024 [S2]
* Exit of HITOWA Holdings, January 2024 [S2]
How this firm fits a seller
Polaris Capital Group appears positioned for Japanese business owners seeking a platform-focused buyer with demonstrated experience across healthcare, technology, and consumer sectors. The firm’s recent transaction history shows both active acquisition activity and successful exits, with four exits completed in the last 24 months alongside six new platform investments [S2]. The presence of offices in Tokyo, Osaka, and Singapore suggests regional operational support capabilities [S1]. For sellers in healthcare services, business software, or specialized manufacturing, the firm’s sector concentration may indicate relevant operational expertise.
Sources
[S1] https://polaris-cg.com/about/map/ (as of 2025-01-07)
[S2] https://polaris-cg.com/portfolio/ (as of 2025-01-07)
Frequently asked questions
Does Polaris Capital Group buy healthcare businesses?
Yes, healthcare and welfare represents one of the firm’s core investment sectors, with four platform companies in this category as of January 2025 [S2]. Recent healthcare acquisitions include Ospherion Biomaterial in July 2024 and Wellbe in April 2024 [S2].
What companies has Polaris Capital Group acquired recently?
Recent acquisitions include Softbrain in January 2026, DD Group in September 2025, and B Food Science in February 2025, per the firm’s portfolio page [S2]. The firm completed six platform acquisitions in the 24 months through January 2026 [S2].
Where is Polaris Capital Group based and how big is the firm?
The firm is headquartered in Tokyo with additional offices in Osaka and Singapore [S1]. The firm is currently investing from Fund 6, though specific fund size or assets under management are not publicly disclosed [S2].
Is Polaris Capital Group still actively acquiring?
Yes, the firm completed its most recent acquisition in January 2026 with the purchase of Softbrain, and has completed six platform investments in the last 24 months [S2]. This activity level suggests ongoing acquisition efforts.
This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.